The upregulation of phosphorylated H2AX was demonstrated with mEHT treatment, which led via the p53/p21waf1 pathway to upregulation and nuclear localization of p21waf1, a potent cyclin-dependent kinase inhibitor responsible for tumor senescence and cell cycle arrest. Here, H2AX is linked to neoplasm.